Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
FCRL3 antisense RNA 1 (FCRL3-AS1) is a long non-coding RNA gene located near the FCRL3 locus. It does not encode a protein and currently has no established therapeutic implications, molecular targets, disease associations, or biomarker status in clinical or translational medicine[4]. FCRL3-AS1 is distinct from the protein-coding gene FCRL3, which encodes Fc receptor-like protein 3—a cell-surface receptor implicated in immune function and autoimmunity[1][2][3]. No alternate compelling aliases or functional insights are currently available for FCRL3-AS1 based on widely recognized reference databases and peer-reviewed literature as of September 2025.
No mechanism of action described, as FCRL3-AS1 is not currently targeted pharmacologically
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on FCRL3 antisense RNA 1 (FCRL3-AS1).